Related Experiment Videos
Diffuse pulmonary opacification in infants undergoing extracorporeal membrane oxygenation: clinical and pathologic
Radiology
|November 1, 1986
Summary
Chest X-rays in infants on extracorporeal membrane oxygenation (ECMO) show diffuse pulmonary opacification. This finding accurately reflects decreased lung compliance and volumes in severe respiratory failure.
Area of Science:
- Pediatric critical care medicine
- Pulmonary imaging
- Neonatology
Background:
- Diffuse pulmonary opacification is a common radiographic finding in infants with severe respiratory failure requiring extracorporeal membrane oxygenation (ECMO).
- The relationship between radiographic findings, clinical severity, and lung mechanics in these patients is not fully understood.
Purpose of the Study:
- To correlate the degree of pulmonary opacification on chest radiographs with clinical severity (ECMO flow rate) and dynamic lung compliance in infants undergoing ECMO.
- To identify pathological changes associated with ECMO therapy and severe respiratory failure.
Main Methods:
- Retrospective review of chest radiographs and clinical records of 18 infants treated with ECMO.
- Radiographic scoring to quantify pulmonary opacification.
- Correlation analysis with ECMO flow rates and dynamic lung compliance measurements.
Main Results:
- A decreasing radiographic score (improving opacification) correlated well with increasing lung compliance and decreasing ECMO flow rates.
- Pathological findings were primarily related to the underlying respiratory condition and intensive respiratory support.
- Diffuse pulmonary hemorrhage was noted in one patient; no other specific ECMO-related pathological features were identified.
Conclusions:
- Pulmonary opacification on chest radiographs in infants on ECMO accurately reflects reduced lung compliance and volumes.
- These changes are attributed to hyaline membrane formation, pulmonary edema, and atelectasis secondary to severe respiratory failure.
- ECMO therapy itself, apart from potential bleeding complications, does not appear to cause distinctive pathological lung changes.